Multiple myeloma: what a non-haematologist should know
Taran K Nandra1, Amarpreet Devi2, John R Jones3
1University Hospitals Sussex NHS Foundation Trust, Brighton, UK taran.nandra@doctors.org.uk.
Clinical Medicine (London, England)
|May 18, 2022
Summary
Multiple myeloma is a common bone marrow cancer. This paper explains its diagnosis, investigations, and management for non-specialists.
Area of Science:
- Hematology
- Oncology
Background:
- Multiple myeloma (MM) is a significant hematological bone marrow malignancy.
- MM represents 2% of new cancer cases in the UK, ranking as the 18th most common cancer.
- Non-specialists often have limited familiarity with MM pathology and initial diagnostic procedures.
Purpose of the Study:
- To outline the key diagnostic features of multiple myeloma.
- To detail the essential investigations required for diagnosing MM.
- To provide a basic management plan for non-specialist healthcare providers.
Main Methods:
- Literature review of diagnostic criteria for multiple myeloma.
- Summary of standard hematological and radiological investigations.
- Outline of general treatment principles for multiple myeloma.
Main Results:
- Diagnostic features include bone pain, anemia, kidney issues, and hypercalcemia.
- Key investigations involve blood tests (serum protein electrophoresis, bone marrow biopsy) and imaging.
- Management focuses on symptom control and referral to specialist care.
Conclusions:
- Early recognition and appropriate investigation are crucial for managing multiple myeloma.
- This guide aims to improve non-specialist understanding and initial patient care.
- Familiarity with MM diagnostics and management enhances patient outcomes.
More Related Videos
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.7K
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.2K
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
Bone Marrow Sampling and Transplants
518
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
518
